Identification of FDA-approved drugs against SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) through computational virtual screening

The SARS-CoV-2 coronavirus is responsible for the COVID-19 outbreak, which overwhelmed millions of people worldwide; hence, there is an urgency to identify appropriate antiviral drugs. This study focuses on screening compounds that inhibit RNA-dependent RNA-polymerase (RdRp) essential for RNA synthe...

Descripción completa

Detalles Bibliográficos
Autores principales: Jade, Dhananjay, Alzahrani, Areej, Critchley, William, Ponnambalam, Sreenivasan, Harrison, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702953/
https://www.ncbi.nlm.nih.gov/pubmed/36467260
http://dx.doi.org/10.1007/s11224-022-02072-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9702953/
https://www.ncbi.nlm.nih.gov/pubmed/36467260
http://dx.doi.org/10.1007/s11224-022-02072-1

Ejemplares similares